Skip to content

Does an app designed to reduce repetitive negative thinking decrease depression and anxiety in young people? A randomized controlled prevention trial

Does an app designed to reduce repetitive negative thinking decrease depression and anxiety in young people? A randomized controlled prevention trial - RETHINK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027384
Enrollment
351
Registered
2022-02-22
Start date
2022-03-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sub-threshold depressive symptoms (prevention of depressive symptoms) Sub-threshold generalized anxiety and social anxiety symptoms (prevention of generalized and social anxiety symptoms), repetitive negative thinking F32 F33 F34

Interventions

Group 1: Participants in intervention arm 1 (n = 117) will receive the full RNT-focused intervention for six weeks via mobile phone app. This intervention will consist of the following elements: psych

Sponsors

Ludwig-Maximilians-Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 22 Years

Inclusion criteria

Inclusion criteria: - Sum scores at or above the 75th percentile on at least one measure of RNT, i.e., either =40 on the Ruminative Response Scale - RRS (Nolen-Hoeksema & Morrow, 1991), and/or, =50 on the Penn State Worry Questionnaire - PSWQ (Meyer, Miller, Metzger, & Borkovec, 1990)

Exclusion criteria

Exclusion criteria: - Current depressive episode as indexed by a sum score > 9 on the Patient Health Questionnaire-9 - PHQ-9 (Spitzer, Kroenke, Williams, Group, & Group, 1999) - Current generalized anxiety disorder as indexed by a sum score > 9 on the Generalized Anxiety Disorder Questionnaire-IV - GADQ-IV (Newman et al., 2002) - Current social anxiety disorder as indexed by a sum score > 35 on the Social Interaction Anxiety Scale – SIAS (Heimberg, Mueller, Holt, Hope, & Liebowitz, 1992) - Currently in psychotherapy

Design outcomes

Primary

MeasureTime frame
Depressive symptoms: sum score on the Inventory of Depressive Symptomatology - IDS (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996) at post-intervention

Secondary

MeasureTime frame
- Generalized anxiety symptoms: sum score on the Generalized Anxiety Disorder Questionnaire-IV - GADQ-IV (Newman et al., 2002) at post intervention - Social anxiety symptoms: sum score on the Social Phobia Inventory – SPIN (Connor et al., 2000) at post intervention - Depressive rumination: sum score on the Ruminative Response Scale - RRS (Nolen-Hoeksema & Morrow, 1991) at post-intervention - Worry: sum score on the Penn State Worry Questionnaire - PSWQ (Meyer, Miller, Metzger, & Borkovec, 1990) at post-intervention - Content-independent RNT: sum score on the Perseverative Thinking Questionnaire - PTQ (Ehring et al., 2011) at post-intervention Additional measures - Self-report measure for depressive episode: Patient Health Questionnaire-9 - PHQ-9 (Spitzer, Kroenke, Williams, Group, & Group, 1999) - Self-report measure for generalized anxiety disorder: Generalized Anxiety Disorder-7 Questionnaire – GAD-7 (Spitzer, Kroenke, Williams, & Löwe, 2006) - Self-report measure for social anxiety disorder: Social Interaction Anxiety Scale – SIAS (Heimberg, Mueller, Holt, Hope, & Liebowitz, 1992)

Countries

Germany

Contacts

Public ContactJulia Funk

Ludwigs-Maximilians-Universität-München, Department Psychologie, Lehrstuhl für Klinische Psychologie und Psychotherapie

KlinischePsychologie08@psy.lmu.de+49-89-2180 5199

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026